Inflammatory Conditions - Zymfentra Prior Authorization Policy

Prior authorization policy for Zymfentra (infliximab-dyyb subcutaneous injection) covering FDA-approved indications Crohn's disease and ulcerative colitis in adults, specifying initial and continuation criteria, prescriber requirements, approval durations, and situations not recommended for approval including concurrent use with other biologics or targeted synthetic oral small molecule drugs.